SignatureFD
RIGL icon

SignatureFD’s Rigel Pharmaceuticals RIGL Stock Holding History

SignatureFD’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.8K Buy
826
+531
+180% +$23.1K ﹤0.01% 2084
2026
Q2 		$11.5K Buy
+295
New +$9.1K ﹤0.01% 2592
2022
Q2 		– Sell
-35
Closed -$1K – 3306
2022
Q1 		$1K Buy
+35
New +$948 ﹤0.01% 3048

Other funds holding RIGL

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SignatureFD's RIGL Position: Q3 2026 in Review

SignatureFD increased its Rigel Pharmaceuticals (RIGL) stake by 180% in Q3 2026, buying an estimated $23.1K and bringing the position to 826 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

SignatureFD first reported a position in RIGL in Q1 2022 and has held it in 3 quarters since. 63 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • SignatureFD held 826 shares of Rigel Pharmaceuticals worth $39.8K as of Q3 2026.
  • SignatureFD bought 531 Rigel Pharmaceuticals shares in Q3 2026, an estimated $23.1K.
  • Rigel Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2084 holding.
  • SignatureFD first reported a position in Rigel Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • 63 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.